MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines10081297

Медицинская библиотека · Vaccines · 2022

Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2.

García-Alanis Mario, Morales-Cárdenas Marisa, Toapanta-Yanchapaxi Liz Nicole, Chiquete Erwin, Núñez Isaac, Ceballos-Liceaga Santa Elizabeth, Carbajal-Sandoval Guillermo, Toledo-Salinas Carla, Mendoza-Hernández David Alejandro, Scheffler-Mendoza Selma Cecilia, Ortega-Martell José Antonio, Carrillo-García Daniel Armando, Hernández-Valdivia Noé, Gutiérrez-Romero Alonso, Galnares-Olalde Javier Andrés, Flores-Silva Fernando Daniel, Díaz-Ortega José Luis, Reyes-Terán Gustavo, López-Gatell Hugo, Cortes-Alcalá Ricardo, Pérez-Padilla José Rogelio, Arauz Antonio, García-Grimshaw Miguel, Valdés-Ferrer Sergio Iván

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Despite the high number of vaccines administered against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, the information on the psychological/psychiatric adverse events following immunization (AEFI) with these newly developed vaccines remains scarce.

OBJECTIVE

To describe the frequency of psychological/psychiatric symptoms among recipients of five different anti-SARS-CoV-2 vaccines and to explore the factors associated with their development reported in the nationwide Mexican registry of AEFI against SARS-CoV-2.

METHODS

Descriptive study of all the psychological/psychiatric symptoms, including anxiety, panic attacks, insomnia, and agitation reported to the Mexican Epidemiological Surveillance System from 21 December 2020 to 27 April 2021, among adult (≥18 years old) recipients of 7,812,845 doses of BNT162b2, ChAdOx1 nCov-19, rAd26-rAd5, Ad5-nCoV, or CoronaVac. The factors associated with their development are determined by multivariate regression analysis.

RESULTS

There were 19,163 AEFI reports during the study period; amongst them, 191 (1%) patients had psychological/psychiatric symptoms (median age of 41 years, interquartile range of 32-54; 149 [78%] women) for an observed incidence of 2.44 cases per 100,000 administered doses (95% confidence interval [CI] 2.12-2.82), 72.8% of psychiatric AEFIs were reported among recipients of BNT162b2. The median time from vaccination to symptom onset was 35 min (interquartile range: 10-720). Overall, the most common psychological/psychiatric symptoms were anxiety in 129 (67.5%) patients, panic attacks in 30 (15.7%), insomnia in 25 (13%), and agitation in 11 (5.7%). After adjusting for the confounding factors, the odds for developing psychological/psychiatric symptoms were higher for those concurrently reporting syncope (odds ratio [OR]: 4.73, 95% CI: 1.68-13.33); palpitations (OR: 2.47, 95% CI: 1.65-3.70), and dizziness (OR: 1.59, 95% CI: 1.10-2.28).

CONCLUSION

In our population, psychological/psychiatric symptoms were extremely infrequent AEFIs. No severe psychiatric AEFIs were reported. Immunization stress-related responses might explain most of the detected cases.

Для цитирования: García-Alanis Mario, Morales-Cárdenas Marisa, Toapanta-Yanchapaxi Liz Nicole, Chiquete Erwin, Núñez Isaac, Ceballos-Liceaga Santa Elizabeth, Carbajal-Sandoval Guillermo, Toledo-Salinas Carla, Mendoza-Hernández David Alejandro, Scheffler-Mendoza Selma Cecilia, Ortega-Martell José Antonio, Carrillo-García Daniel Armando, Hernández-Valdivia Noé, Gutiérrez-Romero Alonso, Galnares-Olalde Javier Andrés, Flores-Silva Fernando Daniel, Díaz-Ortega José Luis, Reyes-Terán Gustavo, López-Gatell Hugo, Cortes-Alcalá Ricardo, Pérez-Padilla José Rogelio, Arauz Antonio, García-Grimshaw Miguel, Valdés-Ferrer Sergio Iván. Psychological and Psychiatric Events Following Immunization with Five Different Vaccines against SARS-CoV-2.. Vaccines. 2022. DOI: 10.3390/vaccines10081297.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.